Low levels of cathepsin D are associated with a poor prognosis in endometrial cancer (Q36618219)

15 August 2017

Low levels of cathepsin D are associated with a poor prognosis in endometrial cancer (English)

1 reference

15 August 2017

Falcón O

1

1 reference

15 August 2017

Chirino R

2

1 reference

15 August 2017

León L

3

1 reference

15 August 2017

López-Bonilla A

4

1 reference

15 August 2017

Torres S

5

1 reference

15 August 2017

Fernández L

6

1 reference

15 August 2017

García-Hernández JA

7

1 reference

15 August 2017

Valerón PF

8

1 reference

15 August 2017

Díaz-Chico JC

9

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

79

1 reference

15 August 2017

3-4

1 reference

15 August 2017

570-576

1 reference

Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis.

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362431

Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362431

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362431

Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies: their correlation with steroid receptors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362431

Stage I endometrial adenocarcinoma: treatment results in 835 patients.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362431

Carcinoma of the endometrium. V. An analysis of prognosticators in patients with favorable subtypes and Stage I disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362431

Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362431

DNA content as a prognostic factor in endometrial carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362431

Cathepsin D in breast cancer: from molecular and cellular biology to clinical applications

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362431

Purification and first characterization of the secreted and cellular 52-kDa proteins regulated by estrogens in human-breast cancer cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362431

Cathepsin D: an independent prognostic factor for metastasis of breast cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362431

Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362431

Cathepsin-D in Human Encjometrium: Induction by Progesterone and Potential Value as a Tumor Marker*

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362431

Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362431

Cathepsin D and prognosis in breast cancer

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362431

Carcinoma of the endometrium: stage I

20 September 2018

1 reference

12 December 2020

The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease

1 reference

12 December 2020

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

1 reference

12 December 2020

Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer

1 reference

12 December 2020

Differential regulation of cathepsin D by sex steroids in mammary cancer and uterine cells

1 reference

12 December 2020

Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II

1 reference

12 December 2020

An integrated set of methods for routine flow cytometric DNA analysis

1 reference

12 December 2020

HER-2/neu expression: a major prognostic factor in endometrial cancer

1 reference

12 December 2020

Prognostic significance of hormone receptors in endometrial cancer

1 reference

12 December 2020

Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer

1 reference

12 December 2020

Comparative quantitative immunohistochemical and immunoradiometric determinations of cathepsin D in endometrial adenocarcinoma: predictors of tumor aggressiveness

1 reference

12 December 2020

Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: correlation with cytosolic assay

1 reference

12 December 2020

Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer

1 reference

12 December 2020

Significance of cathepsin-D expression in uterine tumours

1 reference

12 December 2020

Lack of prognostic value of cathepsin D levels for predicting short term outcomes of breast cancer patients

1 reference

12 December 2020

Progesterone and estrogen control of rates of synthesis of uterine cathepsin D

1 reference

12 December 2020

Quality control of cathepsin-D measurement by the EORTC Receptor Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690090

7 January 2021

Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690090

7 January 2021

Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690090

7 January 2021

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690090

7 January 2021

Correlation of tumor cytosol cathepsin D with differentiation and invasiveness of endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690090

7 January 2021

Flow cytometric measurements of DNA index and S-phase on paraffin-embedded early stage endometrial cancer: an important prognostic indicator

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690090

7 January 2021

Quantitative analyses of epidermal growth factor receptors, HER-2/neu oncoprotein and cathepsin D in nonmalignant and malignant uteri

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690090

7 January 2021

The relative prognostic significance of total cathepsin D and HER-2/neu oncogene amplification in breast cancer. The South Australian Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690090

7 January 2021

Validation of a differential PCR and an ELISA procedure in studying HER-2/neu status in breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690090

7 January 2021

Quantitative analysis of p185(HER-2/neu) protein in breast cancer and its association with other prognostic factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690090

7 January 2021

A secreted glycoprotein induced by estrogen in human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690090

7 January 2021

Identifiers

DOI

10.1038/SJ.BJC.6690090

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

10027332

1 reference